Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Polymorphism 10034C>T in fibrinogen gamma (FGG) gene, total fibrinogen level and risk of coronary artery disease: the Croatian study (CROSBI ID 566161)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | domaća recenzija

Bronić, Ana ; Ferenčak, Goran ; Bernat, Robert ; Dumić-Belamarić, Jerka ; Dabelić, Sanja Polymorphism 10034C>T in fibrinogen gamma (FGG) gene, total fibrinogen level and risk of coronary artery disease: the Croatian study // 10th Congress of the Croatian Society of Biochemistry and Molecular Biology with international participation: The Secret Life of Biomolecules - book of abstracts / Kovarik, Zrinka ; Varljen, Jadranka (ur.). Rijeka: Hrvatsko Društvo za Biotehnologiju, 2010. str. P20-P20

Podaci o odgovornosti

Bronić, Ana ; Ferenčak, Goran ; Bernat, Robert ; Dumić-Belamarić, Jerka ; Dabelić, Sanja

engleski

Polymorphism 10034C>T in fibrinogen gamma (FGG) gene, total fibrinogen level and risk of coronary artery disease: the Croatian study

Coronary artery disease (CAD), the most common type of heart disease, is a leading cause of death and disability throughout the world. Two key events during CAD pathogenesis are atherosclerosis and thrombosis. Recently, a single nucleotide polymorphism (SNP) characterized by a C to T substitution at nucleotide 10034 of the fibrinogen  gene (FGG 10034C>T) has been proposed as a novel risk factor for thrombosis. The aim of this study was to investigate the potential association between FGG 10034C>T polymorphism, total fibrinogen level and risk of CAD. The analysis was performed on subjects who had undergone coronary angiography for investigation of chest pain and suspected CAD in Magdalena Special Hospital for Cardiology in Croatia – overall 114 subjects had angiographically proven CAD (CAD+), while in 68 subjects CAD was angiographically excluded (CAD-). CAD+ patients had >50% stenosis in at least one of the major coronary vessels. FGG genotypes were determined by restriction fragment length polymorphism of the PCR-amplified fragments of DNA isolated from whole blood while fibrinogen levels were measured in plasma. Overall, CC genotype was recorded in 80.2% of subjects (78.9%CAD+ vs. 82.4%CAD-), CT in 18.7% (19.3%CAD+ vs. 17.3% CAD-), and TT in 1.1% (only in 1.8% CAD+) of subjects. The frequency of the rare T allele was 10.4%. There was no significant difference between two groups of patients regarding genotype or allele frequency (p>0.05). Additionally, total fibrinogen levels showed no correlation to patients’ genotype. According to obtained results there is no association between FGG 10034C>T polymorphism and fibrinogen level as well as FGG 10034C>T polymorphism and CAD, although comprehensive case-control study is needed to confirm these preliminary results.

polymorphism; fibrinogen gamma chain; coronary artery disease

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

P20-P20.

2010.

objavljeno

Podaci o matičnoj publikaciji

10th Congress of the Croatian Society of Biochemistry and Molecular Biology with international participation: The Secret Life of Biomolecules - book of abstracts

Kovarik, Zrinka ; Varljen, Jadranka

Rijeka: Hrvatsko Društvo za Biotehnologiju

Podaci o skupu

10th Congress of the Croatian Society of Biochemistry and Molecular Biology with international participation "The secret life of biomolecules"

poster

15.09.2010-18.09.2010

Opatija, Hrvatska

Povezanost rada

Temeljne medicinske znanosti, Biologija